Please login to the form below
Revestive
This page shows the latest Revestive news and features for those working in and with pharma, biotech and healthcare.
Orphan drugs dominate UK Prix Galien shortlist, medtech debuts
Seven companies have been shortlisted for the Orphan Product Award; Amicus (Galafold), Biogen (Spinraza), Biomarin (Brineura), Eusa (Qarziba), Intercept (Ocaliva), Kyowa Kirin (Crysvita) and Shire (Revestive).
Latest news
-
Relief for Shire as FDA clears NPS' Natpara
placebo. Natpara is NPS' second approved product after Gattex/Revestive (teduglutide), a GLP-2 analogue used for the long-term treatment of short bowel syndrome in adults that is expected to
-
Shire signs deal to buy NPS for $5.2bn
Shire chief executive Flemming Ornskov said that the combined company would be able to drive sales of NPS' rare gastrointestinal (GI) disease therapy Gattex/Revestive (teduglutide), a GLP-2 analogue approved
-
European drug applications 'stable but more complex in 2012'
is the first therapy to address the underlying mechanism of CF, and Takeda's Revestive (teduglutide) for treating adults with a rare but debilitating condition known as short bowel syndrome.
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
A rare talent
This is, he adds, “extremely restrictive”, and he points to Revestive (teduglutide), Shire's treatment for the rare and potentially fatal gastrointestinal disorder short bowel syndrome.
-
Interview: Trevor Smith, Takeda
Meanwhile, the company recently won approval for a brace of new products in Europe after regulators gave the greenlight to its short bowel syndrome drug Revestive (teduglutide) in September and approved
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Therachon poaches Shire’s Aled Williams
There he was responsible for the commercialisation and development of Gattex/Revestive (teduglutide) for short bowel syndrome.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- A creative awakening – how pharma is bringing innovation to the patient journey
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- The pharma dichotomy
- Our Top 5 Pharma Picks From Cannes Lions
- Live Webinar: Streamlining the Drug Development Process to Transform Global Health
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Pfizer, Mylan move ahead with generics merger and spin-out
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- Roche shares new positive Ocrevus data for MS patients
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
